Aligos Therapeutics Inc (ALGS)
0.8236
+0.02
(+2.82%)
USD |
NASDAQ |
Apr 23, 16:00
0.8236
0.00 (0.00%)
After-Hours: 20:00
Aligos Therapeutics Price to Book Value: 0.6768 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 0.6768 |
| April 22, 2024 | 0.6582 |
| April 19, 2024 | 0.6163 |
| April 18, 2024 | 0.6517 |
| April 17, 2024 | 0.6467 |
| April 16, 2024 | 0.6862 |
| April 15, 2024 | 0.7352 |
| April 12, 2024 | 0.8218 |
| April 11, 2024 | 0.8711 |
| April 10, 2024 | 0.8546 |
| April 09, 2024 | 0.8711 |
| April 08, 2024 | 0.8793 |
| April 05, 2024 | 0.8546 |
| April 04, 2024 | 0.7992 |
| April 03, 2024 | 0.83 |
| April 02, 2024 | 0.8037 |
| April 01, 2024 | 0.7818 |
| March 28, 2024 | 0.8053 |
| March 27, 2024 | 0.8045 |
| March 26, 2024 | 0.8382 |
| March 25, 2024 | 0.7714 |
| March 22, 2024 | 0.8136 |
| March 21, 2024 | 0.7807 |
| March 20, 2024 | 0.7831 |
| March 19, 2024 | 0.7656 |
| Date | Value |
|---|---|
| March 18, 2024 | 0.756 |
| March 15, 2024 | 0.7573 |
| March 14, 2024 | 0.7147 |
| March 13, 2024 | 0.7149 |
| March 12, 2024 | 0.7149 |
| March 11, 2024 | 0.7232 |
| March 08, 2024 | 0.6904 |
| March 07, 2024 | 0.7585 |
| March 06, 2024 | 0.7993 |
| March 05, 2024 | 0.8154 |
| March 04, 2024 | 0.8075 |
| March 01, 2024 | 0.9216 |
| February 29, 2024 | 0.8074 |
| February 28, 2024 | 0.7829 |
| February 27, 2024 | 0.7748 |
| February 26, 2024 | 0.7422 |
| February 23, 2024 | 0.6117 |
| February 22, 2024 | 0.6524 |
| February 21, 2024 | 0.5432 |
| February 20, 2024 | 0.5218 |
| February 16, 2024 | 0.5301 |
| February 15, 2024 | 0.5236 |
| February 14, 2024 | 0.5301 |
| February 13, 2024 | 0.5203 |
| February 12, 2024 | 0.5546 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2904
Minimum
May 06 2022
6.567
Maximum
Jun 11 2021
1.634
Average
0.6255
Median
Price to Book Value Benchmarks
| Mirum Pharmaceuticals Inc | 4.610 |
| CEL-SCI Corp | 6.273 |
| AIM ImmunoTech Inc | 2.224 |
| IGC Pharma Inc | 3.214 |
| NovaBay Pharmaceuticals Inc | 1.699 |
Price to Book Value Related Metrics
| PS Ratio | 2.714 |
| Price | 0.8236 |
| Earnings Yield | -211.4% |
| Market Cap | 62.32M |